Spanish BMT4me Usability & Acceptability

The objective of this project is to trans-create, conduct user testing of a previously developed and piloted mHealth app, and user acceptability with parents of children in the acute phase post-allogeneic hematopoietic stem cell transplant (HSCT). Nationwide Children's Hospital (NCH) will be the primary data collection site and Columbia University Irving Medical Center will be a secondary site.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bone Marrow Transplant

Age range

0 year–17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Columbia University Irving Medical Center, New York, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Eligible caregivers must have children who:

Are 0-17 years old
Underwent HCT
Are planned for discharge prior to day 100 post-transplant

Primary caregivers must:

Be Spanish speaking
Be ≥18 years old
Have a smartphone (iOS or Android) capable of downloading apps

Exclusion criteria

(a) Children or caregivers with pre-existing neurodevelopmental disorder/disability or a pervasive developmental disorder will be excluded from this study.

Treatment and study plan

BMT4me

Other

Caregivers will pilot test a Spanish version of the BMT4me app at a single time point.

Primary outcomes

Assess app usability using the System Usability Scale (SUS)

Time frame: 6/1/24 - 5/1/26

Data collected using the System Usability Scale (SUS) will provide insight to the usability of the Spanish BMT4Me app in its current form. he SUS is a 10-item questionnaire routinely used to evaluate the functionality and acceptability of mHealth apps. The SUS is scored on a scale, giving a score from from 0 to 100 where 100 is considered the highest rating of usability. A score of > 68 is considered above average.

Sponsors and collaborators

Lead sponsor

Nationwide Children's Hospital

Other

Collaborators

Columbia University

Registry information

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: Apr 11, 2024
Registry last updated: Nov 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed